Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

Research output: Contribution to journalArticle

Standard

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

AU - Mochalina, Natalia

AU - Juhlin, Tord

AU - Platonov, Pyotr

AU - Svensson, Peter

AU - Wieloch, Mattias

PY - 2015

Y1 - 2015

N2 - Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.

AB - Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.

U2 - 10.1016/j.thromres.2015.03.015

DO - 10.1016/j.thromres.2015.03.015

M3 - Article

VL - 135

SP - 1070

EP - 1074

JO - Thrombosis Research

JF - Thrombosis Research

SN - 1879-2472

IS - 6

ER -